You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 8, August 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (50)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Radiation Therapy
 •Alert me on articles by topic

Prophylactic Gastrostomy Tubes in Patients Undergoing Intensive Irradiation for Cancer of the Head and Neck

Jason H. Lee, MD; Mitchell Machtay, MD; Lisa D. Unger, MD; Gregory S. Weinstein, MD; Randal S. Weber, MD; Ara A. Chalian, MD; David I. Rosenthal, MD

Arch Otolaryngol Head Neck Surg. 1998;124:871-875.

Background  Most patients receiving accelerated fractionation radiotherapy or chemoradiotherapy for head and neck cancer experience severe mucositis. This can lead to decreased oral intake, resulting in dehydration, severe malnutrition, hospitalization, and/or interruption of radiotherapy.

Objective  To evaluate the effect of prophylactic gastrostomy tubes (PGTs) on the rates of weight loss, unplanned interruptions, and hospitalization during high-intensity head and neck radiotherapy.

Methods  A retrospective review was performed on 88 patients treated for locally advanced head and neck cancer with accelerated twice-a-day radiation (n = 59) or concurrent chemoradiotherapy (n = 29). Prophylactic gastrostomy tubes were placed in 36 (41%) of patients in anticipation of increased acute toxic effects from treatment. The remaining patients without PGTs served as a control group.

Results  Patients without PGTs lost an average 3.1 kg compared with 7.0 kg in the control group (P<.001). There were significantly fewer hospitalizations for nutritional or dehydration issues in those with PGTs than in the control group (13% vs 34%; P = .04, {chi}2 test). Among those with good performance status, no patient with a PGT required a treatment interruption, compared with 18% of patients without a PGT (P = .08). Sixteen patients (31%) in the control group underwent therapeutic gastrostomy tube placement during or after radiation therapy.

Conclusions  The use of PGTs significantly reduces weight loss and the rate of hospitalization for dehydration and complications of mucositis. Treatment interruptions may also be avoided by the use of PGTs in patients with good performance status. We encourage patients scheduled for intensive radiation therapy to receive a PGT.


From the Department of Radiation Oncology (Drs Lee, Machtay, and Rosenthal), Clinical Nutrition Support Services (Dr Unger), and Department of Otorhinolaryngology (Drs Weinstein, Weber, and Chalian), University of Pennsylvania Medical Center, Philadelphia.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk Factors Predicting Aspiration After Free Flap Reconstruction of Oral Cavity and Oropharyngeal Defects
Smith et al.
Arch Otolaryngol Head Neck Surg 2008;134:1205-1208.
ABSTRACT | FULL TEXT  

Enteral Nutrition Support of Head and Neck Cancer Patients
Raykher et al.
Nutr Clin Pract 2007;22:68-73.
ABSTRACT | FULL TEXT  

Prevention and Treatment of Dysphagia and Aspiration After Chemoradiation for Head and Neck Cancer
Rosenthal et al.
JCO 2006;24:2636-2643.
ABSTRACT | FULL TEXT  

Enteral Access in Home Care
DeLegge
JPEN J Parenter Enteral Nutr 2006;30:S13-S20.
ABSTRACT | FULL TEXT  

Appropriate Use of Artificial Nutrition and Hydration -- Fundamental Principles and Recommendations
Casarett et al.
NEJM 2005;353:2607-2612.
FULL TEXT  

Intensive Chemoradiotherapy as a Primary Treatment for Organ Preservation in Patients With Advanced Cancer of the Head and Neck: Efficacy, Toxic Effects, and Limitations
Hanna et al.
Arch Otolaryngol Head Neck Surg 2004;130:861-867.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.